Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc.

Filing 44

ORDER: A Discovery Conference was held on July 3, 2024, concerning the issues raised in the parties' joint letter (Doc. 40). Counsel for all parties appeared. As explained more fully at the conference, the Court granted in part Plaintiff' s application to compel Defendant to produce documents responsive to Document Request Nos. 23 and 25 (Doc. 40-1), referred to herein as "Design Documents." Specifically, the Court limited Defendants production of Design Documents to those which are dated between March 2022 and September 22, 2023, and which apply and/or relate to Plaintiff's First and Second Claims for Relief for breach of contract. The Court directed Defendant to, by July 10, 2024, advise the Court as to how m uch time is needed to make its production of Design Documents. Additionally, the Court denied Plaintiff's application to compel Defendant to produce documents related to Torcon and Suffolk. Further, as discussed at the conference, Plaintiff sh all make its document production by August 2, 2024. Defendant advised that it intends to file its answer and counterclaims within the time prescribed by the Federal Rules of Civil Procedure. Plaintiff advised that it intends to seek leave to amend t he Complaint. The Court directed the parties to meet and confer regarding the proposed amended complaint. Plaintiff shall, by July 13, 2024, file its pre-motion letter regarding leave to amend the Complaint and annexing both a clean and redlined v ersion of the proposed amended pleading in accordance with Rules 2(C) and 4(C) of this Courts Individual Practices. Should the Court permit the filing of an amended complaint, the parties shall meet and confer and file a proposed amended Case Management Plan and Scheduling Order. See Transcript. SO ORDERED. (Signed by Judge Philip M. Halpern on 7/3/2024) (tg)

Download PDF
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK SKANSKA USA BUILDING INC., Plaintiff, -against- ORDER 23-CV-08418(PMH) REGENERON PHARMACEUTICALS INC., Defendant. PHILIP M. HALPERN, United States District Judge: A Discovery Conference was held on July 3, 2024, concerning the issues raised in the parties’ joint letter (Doc. 40). Counsel for all parties appeared. As explained more fully at the conference, the Court granted in part Plaintiff’s application to compel Defendant to produce documents responsive to Document Request Nos. 23 and 25 (Doc. 40-1), referred to herein as “Design Documents.” Specifically, the Court limited Defendant’s production of Design Documents to those which are dated between March 2022 and September 22, 2023, and which apply and/or relate to Plaintiff’s First and Second Claims for Relief for breach of contract. The Court directed Defendant to, by July 10, 2024, advise the Court as to how much time is needed to make its production of Design Documents. Additionally, the Court denied Plaintiff’s application to compel Defendant to produce documents related to Torcon and Suffolk. Further, as discussed at the conference, Plaintiff shall make its document production by August 2, 2024. Defendant advised that it intends to file its answer and counterclaims within the time prescribed by the Federal Rules of Civil Procedure. Plaintiff advised that it intends to seek leave to amend the Complaint. The Court directed the parties to meet and confer regarding the proposed amended complaint. Plaintiff shall, by July 13, 2024, file its pre-motion letter regarding leave to amend the Complaint and annexing both a clean and redlined version of the proposed amended pleading in accordance with Rules 2(C) and 4(C) of this Court’s Individual Practices. Should the Court permit the filing of an amended complaint, the parties shall meet and confer and file a proposed amended Case Management Plan and Scheduling Order. See Transcript. SO ORDERED: Dated: White Plains, New York July 3, 2024 ____________________________ Philip M. Halpern United States District Judge 2

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?